The U.S. Department of Labor (DOL) has announced an extension of the comment period for its proposed rule regarding fee disclosures by pharmacy benefit managers (PBMs). This rule aims to enhance transparency in the healthcare system by requiring PBMs to provide detailed information about the fees they charge to various stakeholders, including health plans, employers, and consumers. The decision to extend the comment period allows stakeholders more time to review and respond to the proposed regulations, which aim to improve accountability in the pharmaceutical supply chain and reduce costs for patients. The DOL is actively seeking feedback to ensure that the final rule effectively addresses concerns about hidden fees and promotes fair pricing practices in the industry. This initiative is part of a broader effort to increase transparency and competitiveness in healthcare, ultimately benefiting consumers and employers alike.
For more details and the full reference, visit the source link below:
Read the complete article here: http://www.dol.gov/newsroom/releases/ebsa/ebsa20260227